Droxidopa
Product Images NDC 27241-201

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 27241-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (Droxidopa 100mg)

Label for Droxidopa Capsules 100 mg, containing 90 capsules, marketed by Ajanta Pharma USA Inc. The label includes dosing instructions, storage conditions, child-resistant packaging notice, and warnings. It also features the NDC number 27241-199-90, barcode, and space for lot and expiration date.*

FDA Label Image

200mg (Droxidopa 200mg)

Droxidopa Capsules 200 mg label from Ajanta Pharma USA Inc. The label indicates 90 capsules per package. It includes storage instructions, child-resistant packaging, and a barcode. The label features dosage strength prominently and notes it is prescription only.*

FDA Label Image

300mg (Droxidopa 300mg)

The label for Droxidopa Capsules 300 mg shows the product name, strength, and dosage form prominently. It indicates a package of 90 capsules, marketed by Ajanta Pharma USA Inc. The label includes storage instructions, child-resistant packaging notice, and a barcode. The drug is marked Rx only, and packaging details specify a tight, light-resistant container.*

FDA Label Image

Figure1 (Droxidopa Figure 1)

A line graph depicting the mean change in dizziness over 8 weeks in a double-blind treatment phase comparing Droxidopa and placebo groups. The x-axis represents weeks in treatment, and the y-axis shows the mean change in dizziness with baseline set at 5.1 units. Droxidopa shows a greater reduction in dizziness compared to placebo, with statistical significance indicated at week 1 (p<0.05). Error bars are included for variability.*

FDA Label Image

Figure2 (Droxidopa Figure2)

A bar chart showing the percent of subjects versus improvement in OHSA Question 1 scores for two groups: Placebo and Droxidopa. The horizontal axis ranges from -8 (worse) to 8 (better), with bars representing the distribution of subjects' improvements for each group.*

FDA Label Image

Structure (Droxidopa Structure)

Chemical structure diagram of the active ingredient Droxidopa, showing its molecular arrangement of atoms including hydroxyl groups, an amino group, and carboxylic acid function.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.